Zobrazeno 1 - 10
of 338
pro vyhledávání: '"Anat Achiron"'
Autor:
Anat Achiron, Rina Falb, Shay Menascu, David Magalashvili, Mathilda Mandel, Polina Sonis, Michael Gurevich
Publikováno v:
Neurobiology of Disease, Vol 194, Iss , Pp 106475- (2024)
Background: Relapsing-remitting multiple sclerosis (RRMS), a common demyelinating disease among young adults, follows a benign course in 10–15% of cases, where patients experience minimal neurological disability for a decade following disease onset
Externí odkaz:
https://doaj.org/article/cb619171740a4b848d0ab39a9a155a62
Autor:
Martin Vališ, Anat Achiron, Hans Peter Hartung, Jan Mareš, Veronika Tichá, Pavel Štourač, Simona Halusková, Francesco Angelucci, Zbyšek Pavelek
Publikováno v:
Drugs in R&D, Vol 23, Iss 4, Pp 331-338 (2023)
Abstract Multiple sclerosis (MS) is a chronic neurodegenerative disease that affects the central nervous system (CNS). Currently, MS treatment is limited to several Food and Drug Administration (FDA)- and European Medicines Agency (EMA)-approved medi
Externí odkaz:
https://doaj.org/article/7ae609d3e2254eba86eb7e8f90c19741
Autor:
Alasdair J. Coles, Anat Achiron, Anthony Traboulsee, Barry A. Singer, Carlo Pozzilli, Celia Oreja-Guevara, Gavin Giovannoni, Giancarlo Comi, Mark S. Freedman, Tjalf Ziemssen, Debora Shiota, Andreea M. Rawlings, Alana T. Wong, Magdalena Chirieac, Xavier Montalban
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background and objectives: Alemtuzumab demonstrated superior efficacy versus subcutaneous interferon (IFN) beta-1a in participants with relapsing-remitting multiple sclerosis in the 2-year CARE-MS I and II trials. Efficacy was maintained in the 4-yea
Externí odkaz:
https://doaj.org/article/d1ccbb1ea3314b49a9e39f7237862350
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract Multiple Sclerosis (MS) has been linked to a variety of environmental risk factors, including smoking, Epstein-Barr Virus infection, and childhood obesity. There is some evidence to support a relationship between alcohol consumption and MS r
Externí odkaz:
https://doaj.org/article/efb32f91e1bd4005a50d6499de323b46
Autor:
Sapir Dreyer-Alster, Shay Menascu, Mark Dolev, Uri Givon, David Magalashvili, Anat Achiron, Alon Kalron
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Longitudinal data are vital in order to understand intra individual gait changes with the progression of multiple sclerosis (MS). Therefore, the primary aim of this study was to explore the relationship between changes in disability with cha
Externí odkaz:
https://doaj.org/article/a67ee2936fc04584830da07ceec13441
Autor:
Michael Gurevich, Rina Zilkha-Falb, Polina Sonis, David Magalashvili, Shay Menascu, Shlomo Flechter, Mark Dolev, Mathilda Mandel, Anat Achiron
Publikováno v:
International Journal of Infectious Diseases, Vol 115, Iss , Pp 208-214 (2022)
Objectives: Antiviral adaptive immunity involves memory B cells (MBC) and memory T cells (MTC). The dynamics of MBC and MTC in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescents warrant further investigation. Methods: In this
Externí odkaz:
https://doaj.org/article/3d1e511ef56449e28969de1e46ca3cf8
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0280515 (2023)
Although the causes of multiple sclerosis are largely unknown, genetic and environmental components play an important role. Geographic distribution, varying with latitude, reflects both genetic and environmental influences. We conducted a retrospecti
Externí odkaz:
https://doaj.org/article/c4ec31823f444aa1b727493a8c3e4293
Publikováno v:
Neurobiology of Disease, Vol 176, Iss , Pp 105953- (2023)
Background: Pediatric onset multiple sclerosis patients (POMS) are defined as multiple sclerosis with an onset before the age of 18 years. Compared to adult onset multiple sclerosis (AOMS), POMS has more severe disease activity at onset, but better r
Externí odkaz:
https://doaj.org/article/ec50834e71104670a20faf8ef8e1e866
Autor:
Shay Menascu, Roy Aloni, Mark Dolev, David Magalashvili, Keren Gutman, Sapir Dreyer-Alster, Franck Tarpin-Bernard, Ran Achiron, Gil Harari, Anat Achiron
Publikováno v:
Journal of NeuroEngineering and Rehabilitation, Vol 18, Iss 1, Pp 1-8 (2021)
Abstract Background Prevention of cognitive decline in Multiple Sclerosis (MS) is of major importance. We explored the effect of a 6 months computerized game training program on cognitive performance in MS patients with mild cognitive impairment. Met
Externí odkaz:
https://doaj.org/article/f9cd7ace23a244288880e4ee44ad99ed
Autor:
Alon Kalron, Lior Frid, Iliya Fonkatz, Shay Menascu, Mark Dolev, David Magalashvili, Anat Achiron
Publikováno v:
JMIR Serious Games, Vol 10, Iss 3, p e36288 (2022)
BackgroundMultiple sclerosis (MS) is a common nontraumatic, neurological, disabling disease that often presents with upper limb dysfunction. Exercise training has resulted in improvement for patients; however, there can be a lack of compliance due to
Externí odkaz:
https://doaj.org/article/f303d59c77c24010aef06cfbe8bcdbef